U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Mon Mar 31 23:23:43 GMT 2025
Edited
by admin
on Mon Mar 31 23:23:43 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
F68WAH6N5E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZINPENTRAXIN ALFA
USAN   INN  
Official Name English
PRM-151
Preferred Name English
SERUM AMYLOID P-COMPONENT, RECOMBINANT
Common Name English
AMYLOID P COMPONENT, SERUM, RECOMBINANT
Common Name English
RG-30326
Code English
Recombinant human Pentraxin-2
Common Name English
PENTRAXIN 2 (HUMAN)
Common Name English
Zinpentraxin alfa [WHO-DD]
Common Name English
zinpentraxin alfa [INN]
Common Name English
ZINPENTRAXIN ALFA [USAN]
Common Name English
Human serum amyloid P component (SAP, pentraxin-2), non-covalent cyclic homopentamer, produced in Chinese hamster ovary (CHO) cells, glycoform alfa; serum amyloid P component (APCS, SAP, pentraxin 2, pentaxin 2, PTX2, 9.5S ?-1 glycoprotein), non-covalent
Common Name English
RECOMBINANT HUMAN SERUM AMYLOID P
Common Name English
RO-7490677
Code English
RG6354
Code English
RG30326
Code English
PENTRAXIN-2
Common Name English
Serum amyloid P protein (recombinant human PRM 151)
Common Name English
RG-6354
Code English
RO7490677
Code English
PTX-2
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 361111
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
FDA ORPHAN DRUG 416013
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
EU-Orphan Drug EU/3/09/674
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
Code System Code Type Description
UNIPROT
P02743
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
PRIMARY
NCI_THESAURUS
C113177
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
PRIMARY
CAS
1387453-03-3
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
PRIMARY
EVMPD
SUB181451
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
PRIMARY
FDA UNII
F68WAH6N5E
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
PRIMARY
DRUG BANK
DB14852
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
PRIMARY
SMS_ID
100000167062
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
PRIMARY
INN
11816
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
PRIMARY
USAN
KL-86
Created by admin on Mon Mar 31 23:23:43 GMT 2025 , Edited by admin on Mon Mar 31 23:23:43 GMT 2025
PRIMARY
From To
1_36 1_95
2_36 2_95
3_36 3_95
4_36 4_95
5_36 5_95
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_32
N 1_110
N 2_32
N 2_110
N 3_32
N 3_110
N 4_32
N 4_110
N 5_32
N 5_110
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [5_58] [5_59] [5_136] [5_137] [5_138] [5_148] SITE_SPECIFIC CALCIUM BINDING DDENQQ-TYPE 6KHF07E33D
AMINO_ACID_SUBSTITUTION [3_58] [3_59] [3_136] [3_137] [3_138] [3_148] SITE_SPECIFIC CALCIUM BINDING DDENQQ-TYPE 6KHF07E33D
AMINO_ACID_SUBSTITUTION [1_58] [1_59] [1_136] [1_137] [1_138] [1_148] SITE_SPECIFIC CALCIUM BINDING DDENQQ-TYPE 6KHF07E33D
AMINO_ACID_SUBSTITUTION [2_58] [2_59] [2_136] [2_137] [2_138] [2_148] SITE_SPECIFIC CALCIUM BINDING DDENQQ-TYPE 6KHF07E33D
AMINO_ACID_SUBSTITUTION [4_58] [4_59] [4_136] [4_137] [4_138] [4_148] SITE_SPECIFIC CALCIUM BINDING DDENQQ-TYPE 6KHF07E33D
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL